Alcanza Clinical Research
Operates a national network of clinical trial research sites.
Company facts
- Founded
- 2021
- Employees
- 300
- Headquarters
- United States
- CEO
- Carlos Orantes
- Type
- Private
- Funding
- Private Equity · $7.5M · 2021
- Subsidiaries
- Accel Research Sites, ActivMed Practices & Research, Boston Clinical Trials, Coastal Carolina Research Center, FDI Clinical Research, North Georgia Clinical Research, Quest Research Institute, Charlottesville Medical Research, Tampa Bay Medical Research
About
Through groundbreaking technology and a steadfast commitment to inclusivity, we are revolutionizing the clinical trial landscape at Alcanza Clinical Research. Founded with the mission to dismantle barriers to participation, we operate a next-generation site network that ensures medical advancements reflect the diverse populations they are intended to serve. By integrating sophisticated data analytics with community-embedded research facilities, we are accelerating the development of life-saving therapies while prioritizing patient access and safety. Our innovative approach combines operational excellence with a deep-seated dedication to health equity. We leverage advanced clinical trial management systems and electronic data capture technologies to streamline complex study designs across our national network of research sites. From neurology and psychiatry to infectious diseases and general medicine, our expert teams are driving the future of healthcare by delivering high-quality, reliable data to sponsors and providing compassionate, cutting-edge care to participants. At Alcanza, we are not just conducting research; we are shaping a more inclusive and effective future for global health.